참고문헌 (27)

1. Lipinski, C. A., Lombardo, F., Dominy, B. W. and Feeney, P. J. : Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3 (1997). 

   상세보기

2. Lipinski, C. A. : Physicochemical properties in drug design/ development. 2nd International Drug Discovery and Development Summit: Novel Concepts and Technologies to Accelerate Drug Development. Honolulu, HI (2003). 

3. Agharkar, S., Lindenbaum, S. and Higuchi, T. : Enhancement of solubility of drug salts by hydrophilic counter-ions: Properties of organic salts of an anti-malarial drug. J. Pharm. Sci. 65, 747 (1976). 

   상세보기

4. Bastin, R. J., Bowker, M. J. and Slater, B. J. : Salt selection and optimisation procedures for pharmaceutical new chemical entities. Org. Proc. Res. Dev. 4, 427 (2000). 

   상세보기

5. Serajuddin, A. T. M. : Salt formation to improve drug solubility. Adv. Drug Deliv. Rev. 59, 603 (2007). 

   상세보기

6. Dannenfelser, R., He, H., Joshi, Y., Bateman, S. and Serajuddin, A. T. M. : Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycolpolysorbate 80 solid dispersion carrier system. J. Pharm. Sci. 93, 1165 (2004). 

   상세보기

7. Crew, M. D., Curatolo, W. J., Friesen, D. T., Gumkowski, M. J., Lorenz, D. A., Nightlingale, J. A. S., Ruggeri, R. B. and Shanker, R. M. : Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors. US Patent Application 2007/ 0282009 (2007). 

8. Stella, V. J. and Nti-Addae, K. W. : Prodrug strategies to overcome poor water solubility. Adv. Drug Deliv. Rev. 59, 677 (2007). 

   상세보기

9. Merisko-Liversidge, E., Liversidge, G. G. and Cooper, E. R. : Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18, 113 (2003). 

   상세보기

10. Kipp, J. E. : The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 284, 109 (2004). 

    상세보기

11. Kesisoglou, F., Panmai, S. and Wu, Y. : Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631 (2007). 

    상세보기

12. Hauss, D. J. : Oral lipid-based formulations. Adv. Drug Deliv. Rev. 59, 667 (2007). 

    상세보기

13. Crowley, P. J. and Martini, L. G. : Physicochemical approaches to enhancing oral absorption. Pharm. Technol. Eur. 16, 18 (2004). 

    상세보기

14. Strickley, R. G. : Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201 (2004). 

    상세보기

15. Gumkowski, M. J., Fournier, L. A., Tierney, N. K. and Curatolo, W. J. : Improved bioavailability through use of soft gelatin capsule formulations of terlakiren, a tripeptide rennin inhibitor. Pharm. Res. 11, S (1994). 

16. Yu, L., Bridgers, A., Polli, J., Vickers, A., Long, S., Roy, A., Winnike, R. and Coffin, M. : Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. J. Pharm. Sci. 16, 1812 (1999). 

17. Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L. and Borchardt, R. T. : A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 91, 1991 (2002). 

    상세보기

18. Rege, B. D., Kao, J. P. and Polli, J. E. : Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16, 237 (2002). 

    상세보기

19. Seeballuck, F., Ashford, M. B. and O'Driscoll, C. M. : The effects of pluronics block copolymers and cremophor EL on intestinal lipoprotein processing and the potential link with Pglycoprotein in Caco-2 cells. Pharm. Res. 20, 1085 (2003). 

    상세보기

20. Wandel, C., Kim, R. B. and Stein, M. : ''Inactive'' excipients such as Cremophor can affect in vivo drug disposition. Clin. Pharmacol. Ther. 73, 394 (2003). 

    상세보기

21. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C. and Houin, G. : Impact of excipients on the absorption of Pglycoprotein substrates in vitro and in vivo. Int. J. Pharm. 278, 119 (2004). 

    상세보기

22. Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T. and Yamamoto, A. : Modulation of intestinal Pglycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J. Pharm. Sci. 93, 877 (2004). 

    상세보기

23. Pole, D. L. : Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement. J. Pharm. Sci. 97, 1071 (2008). 

    상세보기

24. Kua, M., Li, W., Dulina, W., Donahuea, F., Cade, D., Benameur, H. and Hutchison, K. : Performance qualification of a new hypromellose capsule: Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus(R), Quali-V(R) and gelatin capsules. Int. J. Pharm. 386, 30 (2010). 

    상세보기

25. Rowe, R. C., Sheskey, P. S. and Weller, P. J. : Handbook of Pharmaceutical Excipients, 5th ed. Pharmaceutical Press (London, UK) and the American Pharmacists Association (Washington DC, USA) (2003). 

26. Cole, S. K., Story, M. J., Attwood, D., Laudanski, T., Robertson, J. and Barnwell, S. G. : Studies using a non-ionic surfactantcontaining drug delivery system designed for hard gelatin capsule compatibility. Int. J. Pharm. 88, 211 (1992). 

    상세보기

27. Brown, J., Madit, N., Cole, E. T., Wilding, I. R. and Cade, D. : Effect of cross-linking on the in vivo disintegration of hard gelatin capsules. Pharm. Res. 15, 1026 (1998). 

    상세보기

저자의 다른 논문 :

김동욱 (4) 원권연 (2)